Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans (Q42475650)

1 November 2017

Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans (English)

1 reference

1 November 2017

9

Sabine Werner

1 reference

1 November 2017

Christophe Rosty

3

0 references

Xavier Sastre-Garau

object named as

Xavier Sastre-Garau

10

0 references

François Radvanyi

object named as

François Radvanyi

12

0 references

author name string

Armelle Logié

1

1 reference

1 November 2017

Claire Dunois-Lardé

2

1 reference

1 November 2017

Olivier Levrel

4

1 reference

1 November 2017

Martine Blanche

5

1 reference

1 November 2017

Agnès Ribeiro

6

1 reference

1 November 2017

Jean-Marie Gasc

7

1 reference

1 November 2017

Jose Jorcano

8

1 reference

1 November 2017

Jean Paul Thiery

11

1 reference

1 November 2017

16 March 2005

1 reference

1 November 2017

Human Molecular Genetics

1 reference

1 November 2017

14

1 reference

1 November 2017

1153-1160

1 reference

1 November 2017

9

1 reference

Cell signaling by receptor tyrosine kinases

1 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

RTK mutations and human syndromeswhen good receptors turn bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Genes, growth factors and acanthosis nigricans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Long-term survival in typical thanatophoric dysplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Clinical and biochemical findings of a patient with thanatophoric dysplasia type I: additional finding of dicarboxylic aciduria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Getting under the skin of epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Clonal nature of seborrheic keratosis demonstrated by using the polymorphism of the human androgen receptor locus as a marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

No evidence of somatic FGFR3 mutation in various types of carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI127

21 January 2018

Identifiers

DOI

10.1093/HMG/DDI127

1 reference

1 November 2017

1 reference